Literature DB >> 16751261

A theoretical validation of the substrate depletion approach to determining kinetic parameters.

Abhinav Nath1, William M Atkins.   

Abstract

The substrate depletion approach is an increasingly popular alternative to the traditional method (observing product formation) of determining the kinetic parameters (KM and Vmax) of an enzyme. Obach and Reed-Hagen (Drug Metab Dispos 30:831-837, 2002) used an empirical relationship between substrate depletion rate constants and initial substrate concentration to determine kinetic parameters for a number of cytochrome P450-catalyzed reactions. We present a proof that this relationship can be derived from the Michaelis-Menten equation and, therefore, that kinetic parameters obtained by the substrate depletion approach are equivalent and comparable to those obtained by the traditional product formation approach. Analysis of a simulated data set produced similar kinetic parameters regardless of which approach was used, confirming the theoretical result.

Mesh:

Substances:

Year:  2006        PMID: 16751261     DOI: 10.1124/dmd.106.010777

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  13 in total

1.  Concentration dependence of in vitro biotransformation rates of hydrophobic organic sunscreen agents in rainbow trout S9 fractions: Implications for bioaccumulation assessment.

Authors:  Leslie J Saunders; Simon Fontanay; John W Nichols; Frank A P C Gobas
Journal:  Environ Toxicol Chem       Date:  2019-02-13       Impact factor: 3.742

2.  Measurement of kinetic parameters for biotransformation of polycyclic aromatic hydrocarbons by trout liver S9 fractions: Implications for bioaccumulation assessment.

Authors:  John W Nichols; Melanie A Ladd; Patrick N Fitzsimmons
Journal:  Appl In Vitro Toxicol       Date:  2018

3.  Identification of CYP3A7 for glyburide metabolism in human fetal livers.

Authors:  Diana L Shuster; Linda J Risler; Bhagwat Prasad; Justina C Calamia; Jenna L Voellinger; Edward J Kelly; Jashvant D Unadkat; Mary F Hebert; Danny D Shen; Kenneth E Thummel; Qingcheng Mao
Journal:  Biochem Pharmacol       Date:  2014-10-22       Impact factor: 5.858

4.  1,2,3-Triazole-heme interactions in cytochrome P450: functionally competent triazole-water-heme complexes.

Authors:  Kip P Conner; Preethi Vennam; Caleb M Woods; Matthew D Krzyaniak; Michael K Bowman; William M Atkins
Journal:  Biochemistry       Date:  2012-07-31       Impact factor: 3.162

5.  Fundamentals of Enzyme Kinetics: Michaelis-Menten and Non-Michaelis-Type (Atypical) Enzyme Kinetics.

Authors:  Eleanore Seibert; Timothy S Tracy
Journal:  Methods Mol Biol       Date:  2021

6.  Quantifying Hepatic Enzyme Kinetics of (-)-∆9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, 11-OH-THC, through In Vitro Modeling.

Authors:  Gabriela I Patilea-Vrana; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2019-05-02       Impact factor: 3.922

7.  Catalytic versus inhibitory promiscuity in cytochrome P450s: implications for evolution of new function.

Authors:  Robert S Foti; Mathew Honaker; Abhinav Nath; Josh T Pearson; Brian Buttrick; Nina Isoherranen; William M Atkins
Journal:  Biochemistry       Date:  2011-03-11       Impact factor: 3.162

8.  Contribution of rat intestinal metabolism to the xenobiotics clearance.

Authors:  Mahmud Kajbaf; Raffaella Ricci; Serenella Zambon; Stefano Fontana
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-06-20       Impact factor: 2.441

Review 9.  Rationalization and prediction of in vivo metabolite exposures: the role of metabolite kinetics, clearance predictions and in vitro parameters.

Authors:  Justin D Lutz; Yasushi Fujioka; Nina Isoherranen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-09       Impact factor: 4.481

10.  Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase.

Authors:  Justin D Lutz; Vaishali Dixit; Catherine K Yeung; Leslie J Dickmann; Alex Zelter; Jayne E Thatcher; Wendel L Nelson; Nina Isoherranen
Journal:  Biochem Pharmacol       Date:  2008-10-17       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.